(Q43188626)

15 November 2017

title

Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure (English)

1 reference

15 November 2017

7

1 reference

15 November 2017

Grant A McArthur

9

0 references

author name string

Despina Handolias

1

1 reference

15 November 2017

Renato Salemi

2

1 reference

15 November 2017

William Murray

3

1 reference

15 November 2017

Angela Tan

4

1 reference

15 November 2017

Wendy Liu

5

1 reference

15 November 2017

Amaya Viros

6

1 reference

15 November 2017

John Kelly

8

1 reference

15 November 2017

publication date

20 January 2010

1 reference

Pigment Cell & Melanoma Research

15 November 2017

published in

1 reference

15 November 2017

volume

23

1 reference

15 November 2017

issue

2

1 reference

15 November 2017

page(s)

210-215

1 reference

An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

KIT gene mutations and copy number in melanoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Biology of gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Major response to imatinib mesylate in KIT-mutated melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Imatinib targeting of KIT-mutant oncoprotein in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Determinants of BRAF mutations in primary melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

21 January 2018

Kit signal transduction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

BRAF somatic mutations in malignant melanoma and melanocytic naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

Lack of clinical efficacy of imatinib in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2010.00671.X

10.1111/J.1755-148X.2010.00671.X

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference